ALPK1 Expression Is Associated with Lymph Node Metastasis and Tumor Growth in Oral Squamous Cell Carcinoma Patients.

[1]  Y. Ko,et al.  Arecoline N-Oxide Upregulates Caspase-8 Expression in Oral Hyperplastic Lesions of Mice. , 2017, Journal of agricultural and food chemistry.

[2]  T. Meyer,et al.  ALPK1 and TIFA dependent innate immune response triggered by the Helicobacter pylori type IV secretion system , 2017, bioRxiv.

[3]  Y. Ko,et al.  Combined Genetic Biomarkers and Betel Quid Chewing for Identifying High-Risk Group for Oral Cancer Occurrence , 2017, Cancer Prevention Research.

[4]  Muhammad Sohail Zafar,et al.  Salivary IL-8, IL-6 and TNF-α as Potential Diagnostic Biomarkers for Oral Cancer , 2017, Diagnostics.

[5]  Qing Xu,et al.  TNF-Alpha Promotes Invasion and Metastasis via NF-Kappa B Pathway in Oral Squamous Cell Carcinoma , 2017, Medical science monitor basic research.

[6]  C. Arrieumerlou,et al.  ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria , 2017, PLoS pathogens.

[7]  B. Kuster,et al.  ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer , 2016, Oncotarget.

[8]  P. Chandrasekar,et al.  Overview of immunology of oral squamous cell carcinoma , 2016, Journal of pharmacy & bioallied sciences.

[9]  Liu Liu,et al.  Knockdown of Myosin 6 inhibits proliferation of oral squamous cell carcinoma cells. , 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[10]  Y. Ko,et al.  Down-regulated and Commonly mutated ALPK1 in Lung and Colorectal Cancers , 2016, Scientific Reports.

[11]  Y. Ko,et al.  ALPK1 phosphorylates myosin IIA modulating TNF-α trafficking in gout flares , 2016, Scientific Reports.

[12]  Y. Ko,et al.  ALPK1 affects testosterone mediated regulation of proinflammatory cytokines production , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  K. Yoshizawa,et al.  Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition , 2015, Oncology letters.

[14]  M C Metzger,et al.  Recurrence rate and shift in histopathological differentiation of oral squamous cell carcinoma – A long-term retrospective study over a period of 13.5 years. , 2015, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[15]  Qing Xu,et al.  Expression of E-cadherin and vimentin in oral squamous cell carcinoma. , 2015, International journal of clinical and experimental pathology.

[16]  J. Reifenrath,et al.  Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue – a review , 2014, Diagnostic Pathology.

[17]  Yutaka Kawakami,et al.  Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC , 2014, Molecular Cancer Research.

[18]  E. Thompson,et al.  Targeting EMT in cancer: opportunities for pharmacological intervention. , 2014, Trends in pharmacological sciences.

[19]  M. Krendel,et al.  Non‐muscle myosins in tumor progression, cancer cell invasion, and metastasis , 2014, Cytoskeleton.

[20]  Jiri Polivka,et al.  Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. , 2014, Pharmacology & therapeutics.

[21]  J. Chuang,et al.  Syk/JNK/AP-1 Signaling Pathway Mediates Interleukin-6-Promoted Cell Migration in Oral Squamous Cell Carcinoma , 2014, International journal of molecular sciences.

[22]  M. McCullough,et al.  Chemokines and Cytokines as Salivary Biomarkers for the Early Diagnosis of Oral Cancer , 2013, International journal of dentistry.

[23]  G. Dunn,et al.  Emerging insights into head and neck cancer metastasis , 2013, Head & neck.

[24]  Xudong Wang,et al.  The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases , 2013, Chinese journal of cancer.

[25]  Shih-Feng Tsai,et al.  ALPK1 genetic regulation and risk in relation to gout. , 2013, International journal of epidemiology.

[26]  K. Satoh,et al.  Identification of chromosome 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals by a genome-wide association study , 2013, Journal of Medical Genetics.

[27]  N. D’Silva,et al.  Biomarkers of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma , 2013, Journal of dental research.

[28]  R Rullo,et al.  Prognostic significance of N-Cadherin expression in oral squamous cell carcinoma. , 2011, Anticancer research.

[29]  Tyler E. Miller,et al.  Myosin II isoform switching mediates invasiveness after TGF-β–induced epithelial–mesenchymal transition , 2011, Proceedings of the National Academy of Sciences.

[30]  Y. Ko,et al.  Lymphocyte α-kinase is a gout-susceptible gene involved in monosodium urate monohydrate-induced inflammatory responses , 2011, Journal of Molecular Medicine.

[31]  R. Xu,et al.  Motor coordination deficits in Alpk1 mutant mice with the inserted piggyBac transposon , 2011, BMC Neuroscience.

[32]  Miguel Vicente-Manzanares,et al.  Non-muscle myosin II takes centre stage in cell adhesion and migration , 2009, Nature Reviews Molecular Cell Biology.

[33]  J. Chuang,et al.  CCL5/CCR5 axis promotes the motility of human oral cancer cells , 2009, Journal of cellular physiology.

[34]  H. Zwierzina,et al.  EGFR inhibition as a therapy for head and neck squamous cell carcinoma , 2008 .

[35]  Dong M Shin,et al.  Recent advances in head and neck cancer. , 2008, The New England journal of medicine.

[36]  R. Adelstein,et al.  Nonmuscle myosin II moves in new directions , 2008, Journal of Cell Science.

[37]  N. Takano,et al.  Comparison of salivary cytokine levels in oral cancer patients and healthy subjects. , 2007, The Bulletin of Tokyo Dental College.

[38]  A. Schueler,et al.  Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  J. Bourhis,et al.  Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  A. Ryazanov,et al.  α-Kinase 1, a New Component in Apical Protein Transport* , 2005, Journal of Biological Chemistry.

[41]  H. Watanabe,et al.  Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines. , 2002, Oral oncology.

[42]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[43]  G. Côté,et al.  Specific Phosphorylation of Threonine by theDictyostelium Myosin II Heavy Chain Kinase Family* , 2001, The Journal of Biological Chemistry.

[44]  W. Kobayashi,et al.  Expression of Tumor Necrosis Factor‐α and Interleukin‐6 in Oral Squamous Cell Carcinoma , 1999, Japanese journal of cancer research : Gann.

[45]  A. Ryazanov,et al.  Alpha-kinases: a new class of protein kinases with a novel catalytic domain , 1999, Current Biology.

[46]  T. Egelhoff,et al.  Structural Analysis of Myosin Heavy Chain Kinase A from Dictyostelium , 1995, The Journal of Biological Chemistry.

[47]  M. Clausen,et al.  Small-molecule kinase inhibitors: an analysis of FDA-approved drugs. , 2016, Drug discovery today.

[48]  Stephen L. Abrams,et al.  Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis. , 2015, Advances in biological regulation.

[49]  Shilpa Gupta,et al.  Epidermal growth factor receptor inhibitors: coming of age. , 2014, Cancer control : journal of the Moffitt Cancer Center.

[50]  F. Nunes,et al.  Vimentin in oral squamous cell carcinoma , 2004, European Archives of Oto-Rhino-Laryngology.